Global Mapping of Interventions to Improve Quality of Life of Patients with Alzheimer’s Disease during 1990–2018
Authors:
- 1 January 2019
- journal article
- review article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 48 (5-6) , 221-233
Abstract
Background: Alzheimer’s disease (AD) with its high burden on disability is known as one of the critical public health issues worldwide. Hence, providing comprehensive care and effective symptomatic treatment are becoming a challenge for many healthcare systems. Quality of life (QOL) has been identified as an important indicator to develop holistic care for people living with AD since it reflects treatment response, the progression of AD, and activities of daily living. This study aimed to identify research trends and landscapes as well as important factors in QOL studies in the field of AD. Summary: English research was extracted from the online database Web of Science to analyze research publications’ growth rate and content on AD and QOL. VOSviewer was used to visualize the correlations between terms in titles and abstracts. Research topics were created using Latent Dirichlet Allocation of abstracts’ content and disciplines. Major landscapes in the QOL assessment included care and treatment for AD in epidemiological studies and clinical trials. Besides, most studies were conducted in high-income countries, such as the USA or the United Kingdom. Findings of our study also identified a lack of contextualized factors and research gaps in terms of QOL among individuals with AD. Key Messages: Further studies should be conducted taking an effort to assess QOL among demented patients as well as advancing knowledge, attitude, and practice among family caregivers.Keywords
This publication has 52 references indexed in Scilit:
- Understanding the Pathophysiology of Alzheimer's Disease and Mild Cognitive Impairment: A Mini Review on fMRI and ERP StudiesNeurology Research International, 2012
- Disease-modifying treatments for Alzheimer’s diseaseTherapeutic Advances in Neurological Disorders, 2011
- Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of EfficacyDementia and Geriatric Cognitive Disorders, 2010
- MINI-REVIEW: New national health program against dementia in Japan: The medical center for dementiaPsychogeriatrics, 2010
- Packages of Care for Dementia in Low- and Middle-Income CountriesPLOS Medicine, 2009
- Alzheimer disease: Time to improve its diagnosis and treatmentCleveland Clinic Journal of Medicine, 2009
- Ageing and dementia in low and middle income countries–Using research to engage with public and policy makersInternational Review of Psychiatry, 2008
- A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2005
- Breast Cancer in Younger Women: Reproductive and Late Health Effects of TreatmentJournal of Clinical Oncology, 2003
- A Review of Quality of Life in Alzheimer??s DiseasePharmacoEconomics, 1998